Enorama Pharma AB (publ) (STO:ERMA)

Enorama Pharma AB Revenue

Enorama Pharma AB had revenue of -193.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 3.63M, down -72.70% year-over-year. In the year 2024, Enorama Pharma AB had annual revenue of 15.77M with 1,061.12% growth.

• Revenue (ttm): 3.63M
• Revenue Growth: -72.70%
• P/S Ratio: 32.36
• Revenue / Employee: 726.00K
• Employees: 5
• Market Cap: 117.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	15.77M	14.41M	1,061.12%
Dec 31, 2023	1.36M	-5.49M	-80.17%
Dec 31, 2022	6.85M	-5.95M	-46.50%
Dec 31, 2021	12.80M	8.33M	186.40%
Dec 31, 2020	4.47M	-5.97M	-57.17%